Solufen Warnings





Berlin Pharm
Full Prescribing Info
Warning according to the Notification of Thailand's Ministry of Public Health: Contraindicated in patients who are hypersensitivity to this drug or having asthma, urticaria, or acute sinusitis from aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) hypersensitivity.
Avoid using this drug during the last trimester of pregnancy, unless physician prescribed.
Contraindicated in patients with gastrointestinal hemorrhage or perforated ulcer.
Contraindicated in patients with severe hepatic or renal disease.
Contraindicated in patients with dengue hemorrhagic fever.
Discontinue this drug if erythematous rash or flu-like symptoms occur, and consult physician immediately.
This drug may increase the risk of gastrointestinal bleeding or ulcers.
This drug may increase the risk of stroke and cardiovascular thrombotic events, especially, when using of high dose for a long period of time.
This drug may cause the undesirable effect of fluid retention. Should be used with caution in patient with heart disease and renal impairment.
Use with caution in the treatment of patients with hypertension or elderly.
This drug affects platelets aggregation. Avoid use in individuals suspected dengue hemorrhage fever or platelet disorders from other causes.
Discontinue this drug and consult the physician if having the following signs and symptoms, e.g., fever, erythematous rash, blister, exfoliation of skin and mucous membrane (such as buccal cavity, throat, nose, sexual organ and conjunctivitis) occur because they might be signs and symptoms of Stevens-Johnson syndrome.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in